Nasdaq · CIK 0001326732
XNCR Xencor Inc
Insider trading from SEC Form 4. Last filing Jul 31, 2025. Close $24.63 on Oct 9, 2026, +137% from the 52-week low and -16% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
XNCROct 9, 2026 · close 24.63
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Xencor Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Ellen Feigal director sell | $28k 2,993 shares | -13% | +20% from low-66% from high | |
| 20Weak | Kevin Charles Gorman director sell | $29k 3,173 shares | -14% | +20% from low-66% from high | |
| 20Weak | Kurt A Gustafson director sell | $28k 2,993 shares | -13% | +20% from low-66% from high | |
| 10Weak | Alan Bruce Montgomery director sell | $20k 2,215 shares | -10% | +20% from low-66% from high | |
| 20Weak | Richard J Ranieri director sell | $28k 2,993 shares | -13% | +20% from low-66% from high | |
| 22Weak | Nancy Valente EVP, Chief Development Officer sell | $51k 4,616 shares | -9% | +47% from low-58% from high | |
| 27Weak | Bart Jan Cornelissen SR. VICE PRESIDENT & CFO sell | $30k 3,750 shares | -6% | +3% from low-70% from high | |
| 53Moderate | Bassil I Dahiyat PRESIDENT & CEO sell | $268k 19,716 shares | -4% | - | |
| 41Moderate | John R Desjarlais SR. VICE PRESIDENT & CSO sell | $132k 9,697 shares | -4% | - | |
| 39Weak | Celia Eckert SVP, GENERAL COUNSEL sell | $78k 5,740 shares | -8% | - | |
| 24Weak | Alan Bruce Montgomery director sell | $398k 14,722 shares | -66% | - | |
| 35Weak | Bassil I Dahiyat PRESIDENT & CEO sell | $1.2M 49,278 shares | -12% | - | |
| 7Weak | Bassil I Dahiyat PRESIDENT & CEO sell | $81k 3,366 shares | -1% | - | |
| 23Weak | John R Desjarlais SR. VICE PRESIDENT & CSO sell | $1.6M 68,684 shares | -26% | - |
Transactions
The last 60 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2025 | Raymond Joseph Deshaies director | AGrant or award Stock Option (Right to Buy)derivative | +110,422 | $0.00 | $0 | 110,422 | Jul 31, 2025 |
| Jun 12, 2025 | Todd E Simpson director | AGrant or award Common Stock | +13,686 | $0.00 | $0 | 13,686 | Jun 16, 2025 |
| Jun 12, 2025 | Richard J Ranieri director | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 22,176 | Jun 16, 2025 |
| Jun 12, 2025 | Alan Bruce Montgomery director | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 22,826 | Jun 16, 2025 |
| Jun 12, 2025 | Ellen Feigal director | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 22,176 | Jun 16, 2025 |
| Jun 12, 2025 | Kevin Charles Gorman director | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 22,078 | Jun 16, 2025 |
| Jun 12, 2025 | Barbara Klencke director | AGrant or award Common Stock | +13,686 | $0.00 | $0 | 19,672 | Jun 16, 2025 |
| Jun 12, 2025 | Kurt A Gustafson director | AGrant or award Common Stock10b5-1 | +13,686 | $0.00 | $0 | 23,176 | Jun 16, 2025 |
| Jun 16, 2025 | Ellen Feigal director | SOpen-market sale Common Stock10b5-1 | -2,993 | $9.22 | $28k | 19,183 | Jun 16, 2025 |
| Jun 12, 2025 | Todd E Simpson director | AGrant or award Stock Option (Right to Buy)derivative | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 12, 2025 | Barbara Klencke director | AGrant or award Stock Option (Right to Buy)derivative | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 16, 2025 | Richard J Ranieri director | SOpen-market sale Common Stock10b5-1 | -2,993 | $9.22 | $28k | 19,183 | Jun 16, 2025 |
| Jun 16, 2025 | Alan Bruce Montgomery director | SOpen-market sale Common Stock10b5-1 | -2,215 | $9.22 | $20k | 20,611 | Jun 16, 2025 |
| Jun 16, 2025 | Kurt A Gustafson director | SOpen-market sale Common Stock10b5-1 | -2,993 | $9.22 | $28k | 20,183 | Jun 16, 2025 |
| Jun 16, 2025 | Kevin Charles Gorman director | SOpen-market sale Common Stock10b5-1 | -3,173 | $9.22 | $29k | 18,905 | Jun 16, 2025 |
| Jun 12, 2025 | Kevin Charles Gorman director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 12, 2025 | Ellen Feigal director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 12, 2025 | Alan Bruce Montgomery director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 12, 2025 | Richard J Ranieri director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| Jun 12, 2025 | Kurt A Gustafson director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,372 | $0.00 | $0 | 27,372 | Jun 16, 2025 |
| May 2, 2025 | Nancy Valente EVP, Chief Development Officer | SOpen-market sale Common Stock | -4,616 | $11.03 | $51k | 49,169 | May 6, 2025 |
| Apr 10, 2025 | Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | SOpen-market sale Common Stock | -3,750 | $8.06 | $30k | 61,348 | Apr 14, 2025 |
| Mar 10, 2025 | Bassil I Dahiyat PRESIDENT & CEO | SOpen-market sale Common Stock | -19,716 | $13.60 | $268k | 465,419 | Mar 11, 2025 |
| Mar 10, 2025 | John R Desjarlais SR. VICE PRESIDENT & CSO | SOpen-market sale Common Stock | -9,697 | $13.60 | $132k | 236,574 | Mar 11, 2025 |
| Mar 10, 2025 | Celia Eckert SVP, GENERAL COUNSEL | SOpen-market sale Common Stock | -5,740 | $13.60 | $78k | 63,507 | Mar 11, 2025 |
| Mar 4, 2025 | Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | AGrant or award Common Stock | +21,949 | $0.00 | $0 | 65,098 | Mar 5, 2025 |
| Mar 4, 2025 | Bassil I Dahiyat PRESIDENT & CEO | AGrant or award Common Stock | +109,745 | $0.00 | $0 | 485,135 | Mar 5, 2025 |
| Mar 4, 2025 | Celia Eckert SVP, GENERAL COUNSEL | AGrant or award Common Stock | +21,949 | $0.00 | $0 | 69,247 | Mar 5, 2025 |
| Mar 4, 2025 | John R Desjarlais SR. VICE PRESIDENT & CSO | AGrant or award Common Stock | +29,851 | $0.00 | $0 | 246,271 | Mar 5, 2025 |
| Mar 4, 2025 | Celia Eckert SVP, GENERAL COUNSEL | AGrant or award Stock Option (Right to Buy)derivative | +65,847 | $0.00 | $0 | 65,847 | Mar 5, 2025 |
| Mar 4, 2025 | John R Desjarlais SR. VICE PRESIDENT & CSO | AGrant or award Stock Option (Right to Buy)derivative | +89,552 | $0.00 | $0 | 89,552 | Mar 5, 2025 |
| Mar 4, 2025 | Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | AGrant or award Stock Option (Right to Buy)derivative | +65,847 | $0.00 | $0 | 65,847 | Mar 5, 2025 |
| Mar 4, 2025 | Bassil I Dahiyat PRESIDENT & CEO | AGrant or award Stock Option (Right to Buy)derivative | +329,236 | $0.00 | $0 | 329,236 | Mar 5, 2025 |
| Feb 3, 2025 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Common Stock | +8,808 | $15.69 | $138k | 375,390 | Feb 3, 2025 |
| Feb 3, 2025 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Common Stock | +3,542 | $15.69 | $56k | 216,420 | Feb 3, 2025 |
| Feb 3, 2025 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Stock Option (Right to Buy)derivative | -8,808 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Feb 3, 2025 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Stock Option (Right to Buy)derivative | -3,542 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Dec 2, 2024 | Alan Bruce Montgomery director | MOption exercise Common Stock10b5-1 | +8,293 | $15.35 | $127k | 17,433 | Dec 4, 2024 |
| Dec 2, 2024 | Alan Bruce Montgomery director | MOption exercise Common Stock10b5-1 | +5,008 | $20.00 | $100k | 22,441 | Dec 4, 2024 |
| Dec 2, 2024 | Alan Bruce Montgomery director | SOpen-market sale Common Stock10b5-1 | -13,301 | $27.03 | $360k | 9,140 | Dec 4, 2024 |
| Dec 4, 2024 | Alan Bruce Montgomery director | MOption exercise Common Stock10b5-1 | +991 | $15.35 | $15k | 10,131 | Dec 4, 2024 |
| Dec 4, 2024 | Alan Bruce Montgomery director | MOption exercise Common Stock10b5-1 | +430 | $20.00 | $8,600 | 10,561 | Dec 4, 2024 |
| Dec 4, 2024 | Alan Bruce Montgomery director | SOpen-market sale Common Stock10b5-1 | -1,421 | $27.03 | $38k | 9,140 | Dec 4, 2024 |
| Dec 2, 2024 | Alan Bruce Montgomery director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,008 | $0.00 | $0 | 2,492 | Dec 4, 2024 |
| Dec 2, 2024 | Alan Bruce Montgomery director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,293 | $0.00 | $0 | 6,707 | Dec 4, 2024 |
| Dec 4, 2024 | Alan Bruce Montgomery director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -991 | $0.00 | $0 | 5,716 | Dec 4, 2024 |
| Dec 4, 2024 | Alan Bruce Montgomery director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -430 | $0.00 | $0 | 2,062 | Dec 4, 2024 |
| Nov 21, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Common Stock10b5-1 | +49,278 | $15.69 | $773k | 401,893 | Nov 25, 2024 |
| Nov 21, 2024 | Bassil I Dahiyat PRESIDENT & CEO | SOpen-market sale Common Stock10b5-1 | -49,278 | $24.07 | $1.2M | 352,615 | Nov 25, 2024 |
| Nov 22, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Common Stock10b5-1 | +13,548 | $15.69 | $213k | 366,163 | Nov 25, 2024 |
| Nov 21, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -49,278 | $0.00 | $0 | 22,356 | Nov 25, 2024 |
| Nov 22, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,548 | $0.00 | $0 | 8,808 | Nov 25, 2024 |
| Nov 13, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Common Stock10b5-1 | +3,366 | $15.69 | $53k | 355,981 | Nov 14, 2024 |
| Nov 13, 2024 | Bassil I Dahiyat PRESIDENT & CEO | SOpen-market sale Common Stock10b5-1 | -3,366 | $24.02 | $81k | 352,615 | Nov 14, 2024 |
| Nov 13, 2024 | Bassil I Dahiyat PRESIDENT & CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,366 | $0.00 | $0 | 71,634 | Nov 14, 2024 |
| Nov 11, 2024 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Common Stock10b5-1 | +68,684 | $15.69 | $1.1M | 268,788 | Nov 13, 2024 |
| Nov 11, 2024 | John R Desjarlais SR. VICE PRESIDENT & CSO | SOpen-market sale Common Stock10b5-1 | -68,684 | $23.48 | $1.6M | 200,104 | Nov 13, 2024 |
| Nov 12, 2024 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Common Stock10b5-1 | +12,774 | $15.69 | $200k | 212,878 | Nov 13, 2024 |
| Nov 11, 2024 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -68,684 | $0.00 | $0 | 16,316 | Nov 13, 2024 |
| Nov 12, 2024 | John R Desjarlais SR. VICE PRESIDENT & CSO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,774 | $0.00 | $0 | 3,542 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bart Jan CornelissenSR. VICE PRESIDENT & CFO
- Bassil I DahiyatPRESIDENT & CEO
- Raymond Joseph Deshaiesdirector
- John R DesjarlaisSR. VICE PRESIDENT & CSO
- Celia EckertSVP, GENERAL COUNSEL
- Ellen Feigaldirector
- Kevin Charles Gormandirector
- Kurt A Gustafsoncfo, officer, director
- Barbara Klenckedirector
- Alan Bruce Montgomerydirector
- Richard J Ranieridirector
- Todd E Simpsondirector
- Nancy ValenteEVP, Chief Development Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.